Avian leukosis virus (ALV) induces tumors by integrating its proviral DNA into the chicken genome and altering the expression of nearby genes via strong promoter and enhancer elements. Viral integration sites that contribute to oncogenesis are selected in tumor cells. Deep-sequencing analysis of B-cell lymphoma DNA confirmed that the telomerase reverse transcriptase (TERT) gene promoter is a common ALV integration target. Twenty-six unique proviral integration sites were mapped between 46 and 3,552 nucleotides (nt) upstream of the TERT transcription start site, predominantly in the opposite transcriptional orientation to TERT. Transcriptome-sequencing (RNA-seq) analysis of normal bursa revealed a transcribed region upstream of TERT in the opposite orientation, suggesting the TERT promoter is bidirectional. This transcript appears to be an uncharacterized antisense RNA. We have previously shown that TERT expression is upregulated in tumors with integrations in the TERT promoter region. We now report that the viral promoter drives the expression of a chimeric transcript containing viral sequences spliced to exons 4 through 7 of this antisense RNA. Clonal expansion of cells with ALV integrations driving overexpression of the TERT antisense RNA suggest it may have a role in tumorigenesis.
IMPORTANCEThe data suggest that ALV integrations in the TERT promoter region drive the overexpression of a novel antisense RNA and contribute to the development of lymphomas.
Avian leukosis virus (ALV) is a simple retrovirus that does not carry a viral oncogene but induces tumors by insertional mutagenesis (1, 2). ALV typically induces B-cell lymphomas, but can also induce erythroblastomas, hemangiomas, and myeloid tumors (1-3). Proviral integration can upregulate the expression of nearby genes via strong enhancers and promoter elements in the viral long terminal repeat (LTR) sequences. An advantage of using ALV as an insertional-mutagenesis tool is its relatively random integration pattern, with only a slight preference for actively transcribed sites (4-6). A reduced integration bias allows us to map proviral integrations in many genomic locations and to observe the selection of integration sites with oncogenic potential. Previous studies have shown common integration sites in ALV-induced lymphomas in the MYC, MYB, BIC (miR 155 precursor), and telomerase reverse transcriptase (TERT) genes (6-10). Highthroughput sequencing revealed multiple integration sites in a series of rapid-onset B-cell lymphomas (6). The TERT promoter region was identified as the most clonally expanded of these integrations, suggesting this is an early event in tumorigenesis (6). Twenty-six unique integration sites were identified in the region in multiple independent tumors (6).Telomerase is a ribonucleoprotein complex that adds repeat sequences to chromosome ends. It contains a catalytic protein component, TERT, as well as a noncoding telomerase RNA template component (TERC). Elevated telomerase activity has been detected in more than 90% of all hum...